‘Silo­ing is just so out­dat­ed’: New $350M VC fund aims to dig­i­tize life sci­ences

As tech­nol­o­gy in­creas­ing­ly helps find drug tar­gets, en­hance the di­ag­no­sis of dis­eases, speed up the test­ing of new ther­a­peu­tics and es­sen­tial­ly an­gle its way in­to every cor­ner of life sci­ences, en­tre­pre­neurs will need a new type of VC firm.

At least, that’s the think­ing be­hind the lat­est fund to drop. Di­men­sion, out of New York and San Fran­cis­co, launched Wednes­day with $350 mil­lion to bankroll a cou­ple dozen star­tups, some of which it will help form. The port­fo­lio al­ready in­cludes Kalei­do­scope, mak­er of a tool to help teams keep tabs on R&D, and Enve­da Bio­sciences, which is near­ing the clin­ic.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER